Skip to main content

Cardiosense raises Series A to use AI to detect heart disease

The company hopes to get regulatory clearance for its CardioTag product, a wearable device for wireless patient monitoring.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.